Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
382 Leser
Artikel bewerten:
(2)

Earth Life Sciences, Inc.: Earth Life Sciences Provides Corporate Update on the Progress of the VIVA Health Platform

The Viva Health Platform is Currently in Phase 1 Testing

RENO, NV / ACCESSWIRE / June 22, 2022 / Earth Life Sciences Inc. (OTC PINK:CLTS) ("Earth Life Sciences" or the "Company") is pleased to provide an update on the progress of VivaHealth, a one-stop Smart Life Service Platform designed for Senior Asians.

VivaHealth is a one-stop Internet smart life service trading platform for Asian communities in North America (mainly serving Chinese and other Asian communities). The platform focuses on the vertical fields of skincare and foot bathing, beauty and makeup, manicures, and haircuts, as well as traditional Chinese massages for seniors.

The company's online ordering and offline service is designed as a matching trading platform, similar to Uber, but is targeted to provide lifestyle services. Using Internet information technology and big data for accurate analysis, VivaHealth integrates life service resources such as physiotherapists, foot bathers, manicurists, beauticians, barbers, and medical professionals in the service areas.

According to PolicyAdvice.net, the global healthcare sector will reach $10.059 trillion by 2022. The United States spends significantly more on healthcare, per capita, compared to other nations and such spending is expected to continue growing. The care of the ever-expanding aging population and the development of medical technology have become a huge driving force for the healthcare industry, and the United States will usher in a new era. It is the largest sector in the field of big health. CMS {"Content Management System"} data has shown that national healthcare spending hit a total of $3.8 trillion in the year before the onset of COVID-19.

In the near future, the VIVA USA health platform will be launched in most of the United States, covering hundreds of cities and towns to serve millions of users and families. The developer is presently testing the platform and the Company plans to provide an update on Phase 1 shortly.

About Earth Life Sciences Inc.

In its efforts to enhance shareholder value, Earth Life Sciences is embarking into a new and exciting segment of Personal Care, one of the fastest growing portions of the multi-trillion-dollar Health Care industry. The Company's developer, Viva USA is a company with extensive experience in creating similar systems. Earth Life Sciences has recent AI (Artificial Intelligence) experience and will assist in customization and implementation of advanced innovative software platform which will facilitate the delivery of on-site Life Style Services and well-being to families across the United States under the banner of VIVA USA.

EARTH LIFE SCIENCES INC.

ANGELO MARINO
CEO
1-514-500-4111
info@earthlifesciences.com
info@vivabesthealth.com

Forward Looking Information

This press release contains forward-looking statements. The words "believe," "desirous," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

SOURCE: Earth Life Sciences, Inc.



View source version on accesswire.com:
https://www.accesswire.com/706109/Earth-Life-Sciences-Provides-Corporate-Update-on-the-Progress-of-the-VIVA-Health-Platform

© 2022 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.